126 related articles for article (PubMed ID: 3561578)
1. [Complications following implantatation of a Tenckhoff catheter for the intraperitoneal administration of chemotherapeutic agents].
de Graaf PW; ten Bokkel Huinink WW; Aartsen EJ; Mellema MM; Dubbelman R; Hart AA
Ned Tijdschr Geneeskd; 1987 Feb; 131(8):323-6. PubMed ID: 3561578
[No Abstract] [Full Text] [Related]
2. Complications relating to intraperitoneal administration of cisplatin or carboplatin for ovarian carcinoma.
Sakuragi N; Nakajima A; Nomura E; Noro N; Yamada H; Yamamoto R; Fujimoto S
Gynecol Oncol; 2000 Dec; 79(3):420-3. PubMed ID: 11104613
[TBL] [Abstract][Full Text] [Related]
3. Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter.
Jenkins J; Sugarbaker PH; Gianola FJ; Myers CE
Surg Gynecol Obstet; 1982 Jun; 154(6):858-62. PubMed ID: 7079929
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of complications associated with catheter intraperitoneal chemotherapy of ovarian carcinoma].
Wei LH; Qian HN; Li WF
Zhonghua Fu Chan Ke Za Zhi; 1994 Dec; 29(12):732-4, 762-3. PubMed ID: 7712902
[TBL] [Abstract][Full Text] [Related]
5. Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
Black D; Levine DA; Nicoll L; Chou JF; Iasonos A; Brown CL; Sonoda Y; Chi DS; Leitao MM; Abu-Rustum NR; Ferguson SE; Barakat RR
Gynecol Oncol; 2008 Apr; 109(1):39-42. PubMed ID: 18234300
[TBL] [Abstract][Full Text] [Related]
6. [Functioning of implantable catheters of intraperitoneal chemotherapy].
de Gramont A; Marpeau L; Demuynck B; Gonzalez-Canali G; Pigné A; Herbulot P; Lagadec B; Cady J; Couturier JY; Delfau S
J Gynecol Obstet Biol Reprod (Paris); 1991; 20(3):381-5. PubMed ID: 1869783
[TBL] [Abstract][Full Text] [Related]
7. Tenckhoff catheter placement: surgical aspects.
Cronen PW; Moss JP; Simpson T; Rao M; Cowles L
Am Surg; 1985 Nov; 51(11):627-9. PubMed ID: 4062056
[TBL] [Abstract][Full Text] [Related]
8. Ports and complications for intraperitoneal chemotherapy delivery.
Helm CW
BJOG; 2012 Jan; 119(2):150-9. PubMed ID: 22017885
[TBL] [Abstract][Full Text] [Related]
9. The Groshong catheter as an intraperitoneal access device in the treatment of ovarian cancer patients.
Naumann RW; Alvarez RD; Partridge EE; Kilgore LC; Austin JM
Gynecol Oncol; 1993 Sep; 50(3):291-3. PubMed ID: 8406189
[TBL] [Abstract][Full Text] [Related]
10. The clinical setting and pharmacology of intraperitoneal chemotherapy: an overview.
Myers CE
Semin Oncol; 1985 Sep; 12(3 Suppl 4):12-6. PubMed ID: 4048971
[TBL] [Abstract][Full Text] [Related]
11. Complications associated with intraperitoneal chemotherapy catheters.
Makhija S; Leitao M; Sabbatini P; Bellin N; Almadrones L; Leon L; Spriggs DR; Barakat R
Gynecol Oncol; 2001 Apr; 81(1):77-81. PubMed ID: 11277654
[TBL] [Abstract][Full Text] [Related]
12. Intraperitoneal therapy in the management of patients with ovarian cancer.
McClay EF; Howell SB
Hematol Oncol Clin North Am; 1992 Aug; 6(4):915-26. PubMed ID: 1500393
[TBL] [Abstract][Full Text] [Related]
13. Quiz page. Perforation of a functioning Tenckhoff catheter through the appendix.
George J; Varma S; Gopi SP; Ramachandran S; Thampi M; Kunjukunju M; Pisharody R
Am J Kidney Dis; 2008 Jul; 52(1):A47-8. PubMed ID: 18589212
[No Abstract] [Full Text] [Related]
14. Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.
Meunier F; van der Auwera P; Aoun M; Piccart M; Sculier JP
Scand J Infect Dis Suppl; 1990; 72():26-8. PubMed ID: 2151063
[TBL] [Abstract][Full Text] [Related]
15. Nursing perspectives on intraperitoneal chemotherapy.
Hoff ST
J Intraven Nurs; 1991; 14(5):309-14. PubMed ID: 1748914
[TBL] [Abstract][Full Text] [Related]
16. [Surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
Milczek T; Emerich J; Klasa-Mazurkiewicz D
Ginekol Pol; 2003 Sep; 74(9):817-23. PubMed ID: 14674130
[TBL] [Abstract][Full Text] [Related]
17. Intraperitoneal chemotherapy: technical experience at five institutions.
Piccart MJ; Speyer JL; Markman M; ten Bokkel Huinink WW; Alberts D; Jenkins J; Muggia F
Semin Oncol; 1985 Sep; 12(3 Suppl 4):90-6. PubMed ID: 4048981
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of surgical complications connected with intraperitoneal chemotherapy in ovarian cancer].
Emerich J; Milczek T; Debniak J; Majdak E
Ginekol Pol; 2002 Nov; 73(11):1103-8. PubMed ID: 12722406
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal antineoplastic agents in the management of ovarian cancer.
Tropé C; Kaern J; Vergote I
Eur J Surg Suppl; 1991 May; (561):83-6. PubMed ID: 1720054
[No Abstract] [Full Text] [Related]
20. [The use and nursing of intraperitoneal chemotherapy for ovarian cancer].
Gao SY; Han JH; Li HY
Zhonghua Hu Li Za Zhi; 1996 Apr; 31(4):211-2. PubMed ID: 8826214
[No Abstract] [Full Text] [Related]
[Next] [New Search]
